2-a)pyridin-3-yl)sulfonyl)-1h-pyrazolo(4 Uses, Dosage, Side Effects and more
2-a)pyridin-3-yl)sulfonyl)-1h-pyrazolo(4 is under investigation in clinical trial NCT04270591 (Assess the Anti-tumor Activity and Safety of 2-a)pyridin-3-yl)sulfonyl)-1h-pyrazolo(4 in Patient With Advanced C-met-positive Non-small Cell Lung Cancer).
| Trade Name | 2-a)pyridin-3-yl)sulfonyl)-1h-pyrazolo(4 |
| Generic | Glumetinib |
| Glumetinib Other Names | 6-(1-methyl-1h-pyrazol-4-yl)-1-((6-(1-methyl-1h-pyrazol-4-yl)imidazo(1,2-a)pyridin-3-yl)sulfonyl)-1h-pyrazolo(4,3-b)pyridine |
| Type | |
| Formula | C21H17N9O2S |
| Weight | Average: 459.49 Monoisotopic: 459.122591997 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
